Utah Medical Products Files 8-K on Financials
Ticker: UTMD · Form: 8-K · Filed: Oct 29, 2024 · CIK: 706698
| Field | Detail |
|---|---|
| Company | Utah Medical Products Inc (UTMD) |
| Form Type | 8-K |
| Filed Date | Oct 29, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: UTMD
TL;DR
UTMD filed an 8-K on Oct 29, 2024, for financial reporting. No specific numbers yet.
AI Summary
Utah Medical Products, Inc. filed an 8-K on October 29, 2024, reporting on its results of operations and financial condition, as well as filing financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates that Utah Medical Products, Inc. is providing updates on its financial performance and condition to the SEC, which is important for investors to monitor the company's health.
Risk Assessment
Risk Level: low — The filing is a routine financial reporting document and does not contain information that suggests immediate or significant risk.
Key Players & Entities
- UTAH MEDICAL PRODUCTS, INC. (company) — Registrant
- October 29, 2024 (date) — Date of Report
- 8015661200 (phone_number) — Business Phone
FAQ
What specific financial results are being reported in this 8-K filing?
The provided text states the filing pertains to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits,' but does not detail the specific financial figures or results within this excerpt.
When was this 8-K report filed with the SEC?
The report was filed on October 29, 2024.
What is the primary purpose of this 8-K filing for Utah Medical Products, Inc.?
The primary purpose is to report on the company's results of operations and financial condition, and to file financial statements and exhibits.
What is the principal executive office address for Utah Medical Products, Inc.?
The address is 7043 South 300 West, Midvale, Utah 84047.
What is the SIC code for Utah Medical Products, Inc.?
The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 554 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-10-29 14:47:00
Filing Documents
- utmd-20241029.htm (8-K) — 25KB
- utmd_ex99z1.htm (EX-99.1) — 109KB
- 0001096906-24-002035.txt ( ) — 278KB
- utmd-20241029_def.xml (EX-101.DEF) — 2KB
- utmd-20241029_lab.xml (EX-101.LAB) — 20KB
- utmd-20241029_pre.xml (EX-101.PRE) — 13KB
- utmd-20241029.xsd (EX-101.SCH) — 2KB
- utmd-20241029_htm.xml (XML) — 2KB
02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION
ITEM 2.02—RESULTS OF OPERATIONS AND FINANCIAL CONDITION Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Utah Medical Products, Inc. for the three and nine months ended September 30, 2024 and forward-looking statements relating to 2024 and beyond as presented in a press release dated October 29, 2024. The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
01—FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS The following is filed as an exhibit to this report: Exhibit Number* Title of Document Location Item 99.1 Financial information for Utah Medical Prod ucts, Inc. for the three and nine months ended September 30, 2024 and forward-loo king statements relating to 2024 and beyond as present ed in a press release dated October 29, 2024 . This filing _______________________________________ * All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. Dated: October 29, 2024 By: /s/ Kevin L. Cornwell Kevin L. Cornwell, Chief Executive Officer